drugset / Trial / NCT06809998

COntralateral CorticoSTeroid Injection in Total Knee Arthroplasty

NCT06809998

Phase 1/2 Recruiting 60 enrolled Unity Health Toronto
RandomizedParallel-groupTriple-blindSupportive care

Summary

Through a triple-blinded randomized control trial, the primary purpose of this pilot study is to assess the efficacy of administering peri-operative contralateral corticosteroid injection in patients undergoing TKA. The secondary outcome was to assess the effect of contralateral corticosteroid injection on pain and functional outcomes of patients undergoing TKA.

Timeline

Start
2025-01-24
Primary completion
2026-08-30
Completion
2027-08-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 1 % Other
Subject Bupivacaine Other / unclassified 6 ml Other
Subject Methylprednisolone Other / unclassified 80 mg Other

Indications